Vital Stats in Heart Failure and Electrophysiology

Below we share recent volumes and clinical outcomes from two programs in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: heart failure and recovery, and electrophysiology and cardiac pacing.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

HEART FAILURE AND RECOVERY

2023 Volumes

67

Number of heart transplants, including 4 in pediatric patients and 1 heart/lung transplant

83

Number of left ventricular assist device (LVAD) implantations

312

Number of patient referrals for advanced heart failure

Heart Transplant

Estimated Probability of Surviving With a Functioning Graft*

Time frame	Cleveland Clinic	U.S. benchmark
At 1 year	95.9%	91.2%
At 3 years	92.1%	85.0%
Time frame
At 1 year
Cleveland Clinic
95.9%
U.S. benchmark
91.2%
At 3 years
Cleveland Clinic
92.1%
U.S. benchmark
85.0%

*Unadjusted for patient and donor characteristics.

Source: Scientific Registry of Transplant Recipients program report of 1/9/24.

LVAD Implantation

232

Number of LVAD implants over the past 3 years, among the highest volumes in the U.S. Highest-implanting center in the U.S. in 2023 (N = 83).

93.0%

1-year post-implant survival, primary LVADs (vs. 87% STS Intermacs survival) (for period 4/1/22-9/30/23)

92.4%

1-year post-implant survival, continuous-flow LVADs for destination therapy (vs. 84.7%% STS Intermacs survival) (for period 4/1/22-9/30/23)

Post-Implant Survival Outcomes Since 2006
With Primary LVADs (Continuous Flow)*

Time frame	Cleveland Clinic	STS Intermacs
12 months	85.6%	82.7%
48 months	60.5%	54.9%
60 months	51.8%	46.8%
Time frame
12 months
Cleveland Clinic
85.6%
STS Intermacs
82.7%
48 months
Cleveland Clinic
60.5%
STS Intermacs
54.9%
60 months
Cleveland Clinic
51.8%
STS Intermacs
46.8%

*Data are for period 6/23/06-9/30/23.

Source for LVAD section: Society of Thoracic Surgeons [STS] Intermacs Quarterly Quality Assurance Report, Q3 2023)

ELECTROPHYSIOLOGY (EP)

Overall Volume

31,538

EP lab procedure volume, 2019-2023

6,581

EP lab procedure volume in 2023, highest annual total to date

Lead Extraction

829

Lead extraction procedures, 2019-2023

95.7%

Clinical success rate for lead extractions

0.12%

In-hospital mortality, vs. benchmark of 1.2% (Kusumoto et al., Heart Rhythm. 2017)

Atrial Fibrillation Ablation

6,251

Atrial fibrillation ablations, 2019-2023

1.9%

Major complication rate, vs. benchmark of 2.5% (Hsu et al., J Am Coll Cardiol. 2023)

Ventricular Arrhythmia Ablation

1,423

Ventricular arrhythmia ablations, 2019-2023

4.4%

Major complication rate, vs. benchmark of 10% (Cronin et al., Heart Rhythm. 2020)

Left Atrial Appendage Occlusion (LAAO)

1,068

Watchman^™ and Amplatzer Amulet^™ devices placed for LAAO procedures (includes both EP and interventional cases), 2019-2023

2.2%

Major complication rate within 7 days of LAAO device implant, vs. benchmark of 2.7%-8.7% in published trials (Boersma et al., Eur Heart J. 2016)

Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long tradition of reporting volume and outcomes data across various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.